Searched for
SUPRIYA LIFESCIENCE STOCK PRICE
Will peace get a chance, and bulls make a comeback? 5 large-cap stocks with an upside potential of up to 26%A peace deal, if it comes, will not mean the Gulf region has become stable. It will only mean that current tensions have been paused. The k...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...
- What are US stock market, gold and silver price prediction for Monday? Market outlook after Wall Street gains and metals movementWhat are US stock market, gold and silver price prediction for Monday? Investors are assessing Wall Street's latest gains, developments in ...
- Explained: SpaceX's IPO includes a 'greenshoe' option. Here's what that meansSpaceX's record $75 billion IPO includes a greenshoe option, allowing for the sale of an additional 15% of shares. This standard feature, d...
- Two Trades for Today: 2 pharma companies – a large-cap for a 5% rise, and a mid-cap stock for a gain of 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Sebi plans unified price band across boursesSebi is set to launch an innovative system to regulate stock price limits, focusing on reducing the price variations seen in less liquid st...
- Sebi proposes common price-band mechanism for stocks listed on multiple exchangesSebi has proposed a new mechanism to harmonize stock price bands and pre-open auction prices across exchanges. This aims to address price d...
- Long-term investing: The only play in today’s market; 5 large-caps from different sectors with upside potential of up to 33%Belligerence is back. Both the US and Iran are hitting each other and the statements from both sides do not auger well for a peace deal. Th...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Zydus Lifesciences among 4 stocks that hit 52-week highs & rallied up to 17% in a monthThe Sensex ended marginally higher, while four BSE 200 stocks touched fresh 52-week highs, signaling strong investor confidence. Zydus Life...
- Zydus Lifesciences, 2 other share buybacks closing today. Are you participating?Investors have a final opportunity to tender shares in buyback offers from Zydus Lifesciences, Dhanuka Agritech, and CyberTech Systems and ...
- Meesho: Why Jefferies believes the stock could rally 34% from current levelsJefferies sees significant growth for Meesho. The brokerage initiated coverage with a 'Buy' rating and a target price of Rs 225. This sugge...
- Ather Energy among 5 stocks closing below VWAPFive Nifty500 stocks, including Ather Energy, closed more than 2.5% below their VWAP on June 8, signalling potential bearish momentum. The ...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Top Nifty50 stocks analysts suggest buying in this volatile weekStock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...
- Regulator, cos discuss price hike for some cancer drugsIndia's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...
- Ipca Laboratories among 5 stocks showing bullish RSI upswingFive Nifty500 stocks, including Leela Palaces, Eris Lifesciences, Indian Bank, Mankind Pharma, and Ipca Laboratories, showed bullish moment...
- Supriya Lifescience shares surge 17% on strong Q4 earnings; PAT rises 47% YoYSupriya Lifescience shares jumped over 16% after the company posted a strong Q4FY26 performance, with PAT rising 47% YoY and revenue surgin...
- Zydus Lifesciences buyback alert! Last date to buy shares to participate in Rs 1,100 crore buyback at 7% premiumInvestors must purchase Zydus Lifesciences shares by Wednesday, May 27, to be eligible for the Rs 1,100 crore buyback, as the record date i...
- Stock Radar: Zydus Lifesciences stock breaks out from inverse head & shoulder pattern to hit fresh 52-week high; time to buy?Zydus Lifesciences Ltd. broke out from an inverse head & shoulder pattern, hitting fresh 52-week highs and suggesting continued momentum. E...
Load More
